key: cord-0709115-2of940wu
authors: Al Saiegh, Fadi; Mouchtouris, Nikolaos; Khanna, Omaditya; Baldassari, Michael; Theofanis, Thana; Ghosh, Ritam; Tjoumakaris, Stavropoula; Gooch, M. Reid; Herial, Nabeel; Zarzour, Hekmat; Romo, Victor; Mahla, Michael; Rosenwasser, Robert; Jabbour, Pascal
title: Battle-tested Guidelines and Operational Protocols for Neurosurgical Practice in Times of a Pandemic: Lessons Learned from COVID-19.
date: 2020-10-23
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.10.095
sha: bf0aaf2269f3f1dddf683c86d8127e87252e8817
doc_id: 709115
cord_uid: 2of940wu

The COVID-19 outbreak has led to fundamental disruptions of healthcare and its delivery with sweeping implications for patients and physicians of all specialties, including neurosurgery. In an effort to conserve hospital resources, neurosurgical procedures were classified into tiers to determine which procedures have to be performed in a timely fashion and which ones can be temporarily suspended to aid in the hospital’s reallocation of resources when equipment is scarce. These guidelines were created quickly based on little existing evidence and, thus, were initially variable and required refinement. As the early wave can now be assessed in retrospect, the authors describe the lessons learned and the protocols established based on published global evidence in order to continue to practice neurosurgery sensibly and minimize disruptions. These operational protocols can be applied in a surge of COVID-19 or another airborne pandemic.

The outbreak of Coronavirus disease 2019 in December 2019 has led to fundamental disruptions of healthcare and its delivery affecting every medical specialty. The rapid spread of COVID-19 around the globe caused unprecedented overburdening of our healthcare system, particularly in regions of extreme virus prevalence. In order to avert a collapse of the hospital system due to insufficient ventilators and overrun intensive care units (ICUs), stay-at-home orders were instituted to counteract the spread of disease. In addition, hospitals quickly developed new guidelines based on little existing evidence and, thus, had to adapt 'on the fly'. This had sweeping implications for patients and physicians greatly affecting surgical specialties, including neurosurgery, because elective neurosurgical activity was reduced or eliminated to limit the exposure of both healthcare workers and patients and protect limited resources for the treatment of patients who contracted the virus. As the early wave can now be assessed in retrospect, it becomes increasingly apparent that the healthcare system was not prepared for a pandemic of this magnitude, which resulted in countless lives lost. Nevertheless, the end of COVID- 19 is not yet in sight.

The complications caused by COVID-19 affect a wide range of organ systems. There is accumulating evidence that suggest the presence of a hypercoagulable and inflammatory state that can result in acute stroke or intracranial hemorrhage even in patients without obvious risk factors [1] [2] [3] [4] [5] [6] . Due to the significant implications on neurovascular practices with spikes in case volumes in certain regions, the development of well-defined procedural protocols are of utmost importance. This is key for both the safety of medical staff and patients as well as hospital operations. It is also important to categorize neurosurgical disease into different tiers to continue to treat patients with neurosurgical disease in a timely fashion, before they develop irreversible neurologic deficits.

As more evidence and real-world experience continue to refine the guidelines, the authors describe the lessons learned and the protocols established for the continued sensible neurosurgical practice, which should be applied in a surge of COVID-19 or another airborne pandemic.

J o u r n a l P r e -p r o o f

In the wake of the first wave of COVID-19, institutions created a tiered system in accordance with published guidelines by the American College of Surgeons 7 and international neurosurgical societies 8-10 in an effort to conserve hospital resources. This strategy requires the suspension of some surgical procedures based on the urgency of the underlying disease.

Following those guidelines, neurosurgical procedures can be classified into tiers 11, 12 . Tier 1 is comprised of neurosurgical emergencies, such as aneurysmal subarachnoid hemorrhage, ischemic stroke, or traumatic spinal cord compression (Table 1) . These continue to have the highest priority and patients presenting with these conditions are tested for COVID-19 on admission along with routinely obtained blood work. The patients undergo the required treatment as presumptively COVID-19 positive under full precautions. This is done before the test results are obtained to avoid any delay and further neurologic deterioration.

Patients with primary or metastatic brain tumors near eloquent structures who are deteriorating from mass effect and those with unstable spinal pathology without immediate compromise are classified under tier 2 and should be treated on an urgent or semi-urgent basis within 24-72 hours. Such patients are screened with epidemiological history including recent travel, fever, cough, shortness of breath etc. and are additionally tested with widely-available rapid tests. However, since newly-developed tests are fraught with relatively high false-negative rates, staff are still instructed to be fully compliant with personal protective equipment (PPE).

However, having a documented negative test partially relieves staff from the mental stress that is derived from uncertainty and helps ensure that the patient is not an asymptomatic carrier who can spread the disease to others during their hospital course.

Tier 3 is comprised of conditions that are considered 'elective'. A generally accepted notion are patients who are unlikely to suffer neurological deterioration and include patients scheduled for pain-relief procedures (e. g. spinal cord stimulators, pain pump implants, or lumbar discectomy) or long-term diagnostic testing for epilepsy (such as stereo-encephalography), vagal nerve stimulator placement, or cranioplasty. Surgeries in this category are important to recognize J o u r n a l P r e -p r o o f as their temporary suspension aids in the hospital's reallocation of resources when ventilators or PPEs are scarce and are needed to treat critically-ill patients.

A number of studies have demonstrated that COVID-19 has neuroinvasive potential that leads to an increased risk of cerebrovascular disease, particularly ischemic stroke 2, 13-15 .

However, even in patients with acute neurologic deterioration not related to COVID-19, algorithms have to be implemented to ensure timely triage and treatment of such patients while simultaneously protecting the medical staff. A crucial component is the neuro-anesthesia protocol ( Figure 1 ).

The general consensus is that emergent cases are treated as presumed COVID positive until proven otherwise 16, 17 . In all such cases, full COVID-19 precautions are taken including the use of N95 masks and face shields by all personnel present in the operating room or interventional suite. Traditional surgical masks are worn over the N95 mask to avoid getting blood or other bodily fluids on the N95 to maximize their use period. If the patient arrives intubated, it should be ensured to minimize operating room (OR) or interventional suite staff and shift changes during a procedure as well as the attachment of a High Efficiency Particulate Air (HEPA) at the endotracheal tube. If the patient arrives non-intubated, a series of questions can determine if the patient is at high-risk for COVID-19 18, 19 . These include nursing home residents, recent or current fever, cough, shortness of breath or labored breathing, gastrointestinal symptoms (diarrhea, nausea/vomiting), close contact with a COVID-19 patient, anosmia/hypogeusia, or lymphopenia on complete blood count. If the patient is deemed highrisk, a low threshold for intubation should be maintained even if the procedure does not normally require intubation. This is important because if the patient were to deteriorate and emergent intubation becomes necessary under suboptimal conditions (insufficient planning and PPE use), the risk of aerosolization is high, which puts all present staff at risk of contracting the infection.

If the patient is deemed low-risk and the procedure does not require intubation (e. g. mechanical thrombectomy for ischemic stroke), then the procedure can proceed in accordance to the protocol for non-COVID-19 care. However, all staff should wear N95 masks and eye protection and the J o u r n a l P r e -p r o o f patient should wear a surgical mask overlying the nasal cannula both during the procedure and transport within the hospital.

One of the most drastic changes in neurosurgery upon the stay-at-home orders was the transition to telemedicine. While telemedicine has been used for Medicare patients since the late 1990s, its utilization did not become widespread until the lockdown measures were implemented at our institution on March 13th, 2020. Since then, telemedicine has been used to assess patients 

There are a number of telemedicine software that enable for video communication with Establishing an online outpatient practice allows for more flexible scheduling. Starting telemedicine visits early in the day (e. g. 6:30AM) can be beneficial to accommodate patients who cannot miss work as well as help avoid the network congestion noted later in the day when the rest of the hospital enterprise logs on to carry out their telemedicine visits. Furthermore, preferences on telemedicine scheduling varied among providers; some faculty performed telemedicine visits only on their clinic days, while others saw patients on their operative days, before or after cases, or even on the weekends if necessary.

Additionally, at our institution we have begun to incorporate both fellows and residents on telemedicine to see patients. Neurosurgery is also a select rotation in which medical students participate in telemedicine visits with attending, and this provides an educational opportunity for students to be able to practice history taking skills in a virtual setting. The educational opportunities for telemedicine are tremendous, and make clinic exposure more accessible to trainees.

Telemedicine has also been beneficial in the inpatient setting as well. As neurosurgeons, we are often required to examine patients in a number of settings within a single day: operating room, emergency department, ICU, and clinic. In order to minimize the risk of viral exposure, we have utilized technologies such as the InTouch Health Robot (iRobot, Bedford, MA) and

Zoom (Zoom Video Communications, San Jose, CA) for remote inpatient rounding. More specifically, the health robot has been instrumental in remotely assessing high-risk patients in the ICU or the Emergency Department. It allows for audio and video conferencing with the patient J o u r n a l P r e -p r o o f and family, while keeping the healthcare personnel needed to enter the patient room to a minimum. Additionally, a more affordable and easy-to-use option has been HIPAA-compliant video-conferencing software such as Zoom used via a tablet or a smartphone. Not only does this allow physician-patient communication, but it also seamlessly facilitates multidisciplinary meetings between our team, our colleagues from other services, family members and the patient in one online discussion.

One of the most unsettling components of COVID-19 is seeing subspecialty residents redeployed to any unit where help is needed. When considering where residents will be reassigned and distributed in different phases of the pandemic surge, it is important to consider the skill set of the neurosurgery residents and where they can be of most value. Neurosurgery residents also take pride in being some of the brightest and most efficient workers in the hospital.

They are particularly facile in stressful situations, such as in the ICU setting.

Therefore, it is prudent that in a pandemic, neurosurgery residents lend their service in a niche where they could put these skills to use. This could include working alongside other resident physicians to be part of a "Line Service" to place central and arterial lines in all COVID-19 patients throughout the ICUs in the hospital 11 .

While no subspecialty department wishes to put their residents at unnecessary risk, in a pandemic situation, exposure to COVID-19 patients is somewhat unavoidable. The ACGME has taken a clear stance and offers several guidelines for residents/fellows who require reassignment of clinical duties during this time 21 . In order to keep resident physicians safe, it is important to provide them with educational materials to properly don and doff PPE as well as mandatory inperson sessions with trained clinical staff.

At our institution, none of the neurosurgery residents developed symptoms concerning for COVID-19. Residents were instructed on symptom screening and twice daily temperature checks if inadvertently exposed to a COVID-19-positive patient. Due to an outbreak at one of the facilities among nursing staff in June 2020, all neurosurgery residents were swabbed for COVID-19 around the time of the outbreak, and every resident had a negative result. While this is J o u r n a l P r e -p r o o f certainly a unique circumstance, we do recommend that leadership of neurosurgical departments be prepared to handle a potential outbreak amongst faculty or resident physicians. This includes providing fast and efficient testing -which was done for all the residents at a central testing site on campus. Not only is this important to quarantine any team members who are asymptomatic carriers, but it also gives residents 'peace of mind' in times when mental health is already at risk.

Conference cancellations, travel restrictions, and limited in-person gatherings act as barriers to academic learning and compromise resident education. Since COVID-19 is an ongoing issues and surge in pandemic cases can lead to the suspension of non-emergent surgeries, our department has transitioned to recurrent didactic events using videoconference software (e. g. Zoom Video Communications, San Jose, CA). This includes weekly grand rounds, case conferences, and journal clubs led by neurosurgical faculty. Prior to each didactic event, review materials were sent out via email to ensure active participation and contribution of a lively discussion. To simplify participation, all didactic events were scheduled at the same times as preexisting programs and recurrent events had the identical log-in identifier from week to week.

It goes without saying that videoconference meetings and group discussions do not replace the training in the operating room. However, they keep the residents' engaged and improve their critical thinking and surgical planning in times of a reduced case volume. Future advancements could be made by the implementation of augmented reality platforms to improve anatomical knowledge and surgical skills. Finally, video conference meetings are also instrumental in future resident and fellow recruitment 22 .

Another cornerstone of resident and department camaraderie is the implementation of video meetings via Zoom (San Jose, CA, USA) twice a week, which is particularly useful when elective surgeries are placed on hold. These meetings include the residents as well as the Chairman and Residency Program Director to transparently discuss any new measures taken by administration. The meetings also serve to build team morale as personal interaction is naturally reduced when elective surgeries are placed on hold.

J o u r n a l P r e -p r o o f A limitation of our article may be the limited applicability to neurosurgical practice in developing countries.

The COVID-19 pandemic caused fundamental disruptions of neurosurgical practice.

However, the instituted protocols proved to be efficient in providing a safe environment to continue to provide neurosurgical care to patients and help facilitate resident education.

Unfortunately, the end is not yet in sight, but the lessons learned from this pandemic can be applied to a future airborne pandemic or a second wave for better damage control.

J o u r n a l P r e -p r o o f

Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke

COVID-19 Is an Independent Risk Factor for Acute Ischemic Stroke

COVID-19: consider cytokine storm syndromes and immunosuppression

Thrombotic Neurovascular Disease in COVID-19 Patients. Neurosurgery. 2020

Letter to the Editor: Incidence of Acute Ischemic Stroke and Rate of Mechanical Thrombectomy During the COVID-19 Pandemic in a Large Tertiary Care Telemedicine Network. World neurosurgery

Cerebral deep venous thrombosis and COVID-19: case report

Managing COVID-19 in Surgical Systems

Neurosurgical Practice During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Worldwide Survey

Neurosurgery Residency in the COVID-19 Era: Experiences and Insights From Thomas Jefferson University Hospital

The Coronavirus Disease

Global Pandemic: A Neurosurgical Treatment Algorithm

Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway

Results from a Retrospective Consecutive Neuroimaging Cohort. Radiology. 2020: 202791

Mechanisms of Stroke in COVID-19

European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section

Clinical Characteristics and Outcomes of 421 Patients With Coronavirus Disease

Clinical characteristics of emergency surgery patients infected with coronavirus disease 2019 (COVID-19) pneumonia in Wuhan, China. Surgery

Telemedicine in Neurosurgery: Lessons Learned and Transformation of Care During the COVID-19 Pandemic

Virtual Residency Training Interviews in the Age of COVID-19 and Beyond. World neurosurgery

No funding from any source was received for the preparation of this work.Conflict of interest: None. All authors declare that they do not have any personal or institutional financial interest in drugs, materials, or devices described in this submission.Ethics Approval: This work describes established guidelines and protocols with no patient participation and no requirement for Institutional Review Board approval.All authors hereby confirm that (1) this research data has not been previously published and is not currently elsewhere under consideration for publication. (2) All authors have read and approved the manuscript.J o u r n a l P r e -p r o o f

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:J o u r n a l P r e -p r o o f